Browse

You are looking at 401 - 450 of 1,337 items for :

  • Clinical Resources x
  • Refine by Access: All content x
Clear All
Restricted access

12 Interpretation of Laboratory Tests Associated with the Assessment of Nutritional Status

Lingtak-Neander Chan and Sharon Wu

Restricted access

5 Interpretation of Serum Drug Concentrations

Riane Ghamrawi and Lindsay Benedik

Restricted access

23 Interpreting Pediatric Laboratory Data

Jessica L. Jacobson, Beth S. Shields, and Donna M. Kraus

Restricted access

2 Introduction to Common Laboratory Assays and Technology

Nicholas M. Moore

Restricted access

Isoniazid Suspension 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Isradipine Syrup 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Itraconazole Suspension 20 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Itraconazole Suspension 20 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Itraconazole Syrup 40 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Ketoconazole Suspension 20 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Ketoconazole Suspension 20 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Ketoprofen Suspension 20 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Labetalol Hydrochloride Suspension 40 mg/mL—Formulation 1*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Labetalol Hydrochloride Suspension 40 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Labetalol Hydrochloride Syrup 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Lamotrigine Suspension 1 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Lamotrigine Suspension 1 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Lansoprazole Solution 3 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Lansoprazole Suspension 3 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Lapatinib Suspension 50 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Lenalidomide Suspension 1.25 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

LET (Lidocaine 4%/Racepinephrine 0.225%/Tetracaine 0.5%) Topical Solution

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Levodopa 5 mg/mL and Carbidopa 1.25 mg/mL Suspension—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Levodopa 5 mg/mL and Carbidopa 1.25 mg/mL Suspension—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Levofloxacin Suspension 50 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Levofloxacin Suspension 50 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Levothyroxine Sodium Solution 25 mcg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

16 LIDOCAINE

Toby C. Trujillo

Restricted access

8 Lipid Disorders

Jill S. Borchert and Kathy E. Komperda

Restricted access

Lisinopril Suspension 1 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Lisinopril Suspension 1 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Lisinopril Syrup 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Lisinopril Syrup 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

17 LITHIUM

Tanya J. Fabian and Matthew A. Fuller

Restricted access

CH 1.9 Lithium

John E. Murphy

Restricted access

CH 2.9 Lithium

John E. Murphy

Restricted access

15 Liver and Gastroenterology Tests

Paul Farkas, Joanna Sampson, Matthew Slitzky, and Jason Altman

Restricted access

Lorazepam Suspension 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Losartan Suspension 2.5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

CH 1.2 Medication Dosing in Overweight and Obese Patients

John E. Murphy

Restricted access

CH 2.2 Medication Dosing in Overweight and Obese Patients

John E. Murphy

Restricted access

4 MEDICATION DOSING IN OVERWEIGHT AND OBESE PATIENTS

Brian L. Erstad

Restricted access

Melatonin 1 mg/mL and Pyridoxine Hydrochloride 3.3 mg/mL Suspension

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Melatonin Suspension 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Melatonin Suspension 3 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

25 Men’s Health

Mary Lee and Roohollah Sharifi

Restricted access

Mercaptopurine Suspension 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Mercaptopurine Syrup 50 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Methadone Hydrochloride Suspension 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Methotrexate Syrup 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes